These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31403685)

  • 21. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
    Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
    J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
    Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
    PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine.
    Barateiro LGRP; de Oliveira Cavagna R; Dos Reis MB; de Paula FE; Teixeira GR; Moreno DA; Bonatelli M; Santana I; Saggioro FP; Neder L; Stavale JN; Malheiros SMF; Garcia-Rivello H; Christiansen S; Nunes S; da Costa MJG; Pinheiro J; Júnior CA; Mançano BM; Reis RM
    Neuropathology; 2024 May; ():. PubMed ID: 38736183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
    Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
    Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
    Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
    Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
    Bharambe HS; Paul R; Panwalkar P; Jalali R; Sridhar E; Gupta T; Moiyadi A; Shetty P; Kazi S; Deogharkar A; Masurkar S; Yogi K; Kunder R; Gadewal N; Goel A; Goel N; Chinnaswamy G; Ramaswamy V; Shirsat NV
    Acta Neuropathol Commun; 2019 Apr; 7(1):52. PubMed ID: 30944042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort.
    Stock A; Mynarek M; Pietsch T; Pfister SM; Clifford SC; Goschzik T; Sturm D; Schwalbe EC; Hicks D; Rutkowski S; Bison B; Pham M; Warmuth-Metz M
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1811-1817. PubMed ID: 31649159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medulloblastoma comprises four distinct molecular variants.
    Northcott PA; Korshunov A; Witt H; Hielscher T; Eberhart CG; Mack S; Bouffet E; Clifford SC; Hawkins CE; French P; Rutka JT; Pfister S; Taylor MD
    J Clin Oncol; 2011 Apr; 29(11):1408-14. PubMed ID: 20823417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
    Zhukova N; Ramaswamy V; Remke M; Martin DC; Castelo-Branco P; Zhang CH; Fraser M; Tse K; Poon R; Shih DJ; Baskin B; Ray PN; Bouffet E; Dirks P; von Bueren AO; Pfaff E; Korshunov A; Jones DT; Northcott PA; Kool M; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognár L; Cho BK; Eberhart CG; Conter CF; Fouladi M; French PJ; Grajkowska WA; Gupta N; Hauser P; Jabado N; Vasiljevic A; Jung S; Kim SK; Klekner A; Kumabe T; Lach B; Leonard JR; Liau LM; Massimi L; Pollack IF; Ra YS; Rubin JB; Van Meir EG; Wang KC; Weiss WA; Zitterbart K; Bristow RG; Alman B; Hawkins CE; Malkin D; Clifford SC; Pfister SM; Taylor MD; Tabori U
    Acta Neuropathol Commun; 2014 Dec; 2():174. PubMed ID: 25539912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas.
    Lindsey JC; Hill RM; Megahed H; Lusher ME; Schwalbe EC; Cole M; Hogg TL; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    J Clin Oncol; 2011 Apr; 29(12):e344-6; author reply e347-8. PubMed ID: 21357788
    [No Abstract]   [Full Text] [Related]  

  • 34. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets.
    Marques RF; Moreno DA; da Silva L; Leal LF; de Paula FE; Santana I; Teixeira G; Saggioro F; Neder L; Junior CA; Mançano B; Reis RM
    Front Immunol; 2023; 14():1062856. PubMed ID: 36825029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
    Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O
    J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
    Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
    Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].
    Wataya T; Hamasaki M; Taylor MD
    No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
    Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
    Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medulloblastoma. Pathology].
    Siegfried A; Delisle MB
    Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2 overexpression is associated with short survival in adults with medulloblastoma.
    Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A
    Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.